158017 — Neomycin-polymyxin-hydrocort 3.5 Mg/ml-10,000 Unit/ml-1 % Ear Solution
Cite this view
HANK Price Transparency. (n.d.). neomycin-polymyxin-hydrocort 3.5 mg/mL-10,000 unit/mL-1 % ear solution (OTHER 158017) negotiated rates. PPMan price-transparency data, derived from CMS-required hospital MRFs. Retrieved , from http://ppman.hank.ai/transparency/code/158017?code_type=OTHER
“neomycin-polymyxin-hydrocort 3.5 mg/mL-10,000 unit/mL-1 % ear solution (OTHER 158017) negotiated rates.” HANK Price Transparency, http://ppman.hank.ai/transparency/code/158017?code_type=OTHER. Accessed .
“neomycin-polymyxin-hydrocort 3.5 mg/mL-10,000 unit/mL-1 % ear solution (OTHER 158017) negotiated rates,” HANK Price Transparency, accessed , http://ppman.hank.ai/transparency/code/158017?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital machine-readable files (45 CFR 180). See methodology.
Usually $5,109–$5,109 (25th–75th percentile) across 1 hospital · 1 payer.
“Negotiated” is the hospital’s negotiated facility rate for this OTHER 158017 — the consumer-grade median across the country. It covers the facility charge only; the surgeon’s and anesthesiologist’s fees are billed separately.
Per-month price trends are temporarily unavailable while we rebuild them on quality-filtered rates. The medians, percentiles, and per-hospital rates on this page are the quality-filtered figures.
Hospital rates (per row)
Showing consumer-grade rates only. Flagged / outlier filings (excluded from the medians above) are hidden — tick “Show flagged / outlier rates” to include them.
| Hospital | Payer | Plan | Negotiated rate | Gross | Cash | Observed | Source |
|---|---|---|---|---|---|---|---|
| LARNED STATE HOSPITAL Inpatient | Insurance | Insurance | $5,109.24 | $5,109.24 | $5,109.24 | 2026-07-31 | MRF ↗ |